Literature DB >> 7518828

Tumor necrosis factor-alpha inhibits stem cell factor-induced proliferation of human bone marrow progenitor cells in vitro. Role of p55 and p75 tumor necrosis factor receptors.

L S Rusten1, E B Smeland, F W Jacobsen, E Lien, W Lesslauer, H Loetscher, C M Dubois, S E Jacobsen.   

Abstract

Stem cell factor (SCF), a key regulator of hematopoiesis, potently synergizes with a number of hematopoietic growth factors. However, little is known about growth factors capable of inhibiting the actions of SCF. TNF-alpha has been shown to act as a bidirectional regulator of myeloid cell proliferation and differentiation. This study was designed to examine interactions between TNF-alpha and SCF. Here, we demonstrate that TNF-alpha potently and directly inhibits SCF-stimulated proliferation of CD34+ hematopoietic progenitor cells. Furthermore, TNF-alpha blocked all colony formation stimulated by SCF in combination with granulocyte colony-stimulating factor (CSF) or CSF-1. The synergistic effect of SCF observed in combination with GM-CSF or IL-3 was also inhibited by TNF-alpha, resulting in colony numbers similar to those obtained in the absence of SCF. These effects of TNF-alpha were mediated through the p55 TNF receptor, whereas little or no inhibition was signaled through the p75 TNF receptor. Finally, TNF-alpha downregulated c-kit cell-surface expression on CD34+ bone marrow cells, and this was predominantly a p55 TNF receptor-mediated event as well.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7518828      PMCID: PMC296294          DOI: 10.1172/JCI117303

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  64 in total

1.  Net increase of pluripotential hematopoietic precursors in suspension culture in response to IL-1 and IL-3.

Authors:  N N Iscove; A R Shaw; G Keller
Journal:  J Immunol       Date:  1989-04-01       Impact factor: 5.422

2.  Intralesional tumour necrosis factor combined with interferon gamma in metastatic melanoma.

Authors:  S Retsas; M Leslie; D Bottomley
Journal:  BMJ       Date:  1989-05-13

3.  Positive and negative effects of tumor necrosis factor on colony growth from highly purified normal marrow progenitors.

Authors:  B Backx; L Broeders; F J Bot; B Löwenberg
Journal:  Leukemia       Date:  1991-01       Impact factor: 11.528

4.  Tumor necrosis factor downregulates granulocyte-colony-stimulating factor receptor expression on human acute myeloid leukemia cells and granulocytes.

Authors:  O Elbaz; L M Budel; H Hoogerbrugge; I P Touw; R Delwel; L A Mahmoud; B Löwenberg
Journal:  J Clin Invest       Date:  1991-03       Impact factor: 14.808

5.  Cloning and expression of cDNAs for two distinct murine tumor necrosis factor receptors demonstrate one receptor is species specific.

Authors:  M Lewis; L A Tartaglia; A Lee; G L Bennett; G C Rice; G H Wong; E Y Chen; D V Goeddel
Journal:  Proc Natl Acad Sci U S A       Date:  1991-04-01       Impact factor: 11.205

6.  Human tumor necrosis factor alpha (TNF alpha) mutants with exclusive specificity for the 55-kDa or 75-kDa TNF receptors.

Authors:  H Loetscher; D Stueber; D Banner; F Mackay; W Lesslauer
Journal:  J Biol Chem       Date:  1993-12-15       Impact factor: 5.157

7.  Tumor necrosis factor (TNF)-alpha but not TNF-beta induces secretion of colony stimulating factor for macrophages (CSF-1) by human monocytes.

Authors:  W Oster; A Lindemann; S Horn; R Mertelsmann; F Herrmann
Journal:  Blood       Date:  1987-11       Impact factor: 22.113

8.  Granulocyte colony-stimulating factor enhances interleukin 3-dependent proliferation of multipotential hemopoietic progenitors.

Authors:  K Ikebuchi; S C Clark; J N Ihle; L M Souza; M Ogawa
Journal:  Proc Natl Acad Sci U S A       Date:  1988-05       Impact factor: 11.205

9.  The dominant-white spotting (W) locus of the mouse encodes the c-kit proto-oncogene.

Authors:  E N Geissler; M A Ryan; D E Housman
Journal:  Cell       Date:  1988-10-07       Impact factor: 41.582

10.  Effects of recombinant tumor necrosis factor, lymphotoxin, and immune interferon on proliferation and differentiation of enriched hematopoietic precursor cells.

Authors:  M Murphy; B Perussia; G Trinchieri
Journal:  Exp Hematol       Date:  1988-02       Impact factor: 3.084

View more
  13 in total

1.  Ablation of TNF-RI/RII expression in Alzheimer's disease mice leads to an unexpected enhancement of pathology: implications for chronic pan-TNF-α suppressive therapeutic strategies in the brain.

Authors:  Sara L Montgomery; Michael A Mastrangelo; Diala Habib; Wade C Narrow; Sara A Knowlden; Terry W Wright; William J Bowers
Journal:  Am J Pathol       Date:  2011-08-09       Impact factor: 4.307

2.  Upregulation of tumor necrosis factor-alpha gene by Epstein-Barr virus and activation of macrophages in Epstein-Barr virus-infected T cells in the pathogenesis of hemophagocytic syndrome.

Authors:  J D Lay; C J Tsao; J Y Chen; M E Kadin; I J Su
Journal:  J Clin Invest       Date:  1997-10-15       Impact factor: 14.808

3.  Sunitinib facilitates the activation and recruitment of therapeutic anti-tumor immunity in concert with specific vaccination.

Authors:  Anamika Bose; Jennifer L Taylor; Sean Alber; Simon C Watkins; Jorge A Garcia; Brian I Rini; Jennifer S Ko; Peter A Cohen; James H Finke; Walter J Storkus
Journal:  Int J Cancer       Date:  2011-05-25       Impact factor: 7.396

4.  The soluble Notch ligand, Jagged-1, inhibits proliferation of CD34+ macrophage progenitors.

Authors:  Masahiro Masuya; Naoyuki Katayama; Natsuki Hoshino; Hiroyoshi Nishikawa; Seiji Sakano; Hiroto Araki; Hidetsugu Mitani; Hirohito Suzuki; Hiroyuki Miyashita; Kyoko Kobayashi; Kazuhiro Nishii; Nobuyuki Minami; Hiroshi Shiku
Journal:  Int J Hematol       Date:  2002-04       Impact factor: 2.490

5.  Monocyte-macrophage differentiation in vitro: modulation by extracellular matrix protein substratum.

Authors:  Shiney Susan Jacob; Padma Shastry; P R Sudhakaran
Journal:  Mol Cell Biochem       Date:  2002-04       Impact factor: 3.396

6.  Phosphatidylinositol transfer proteins regulate megakaryocyte TGF-β1 secretion and hematopoiesis in mice.

Authors:  Maegan Capitano; Liang Zhao; Scott Cooper; Chelsea Thorsheim; Aae Suzuki; Xinxin Huang; Alexander L Dent; Michael S Marks; Charles S Abrams; Hal E Broxmeyer
Journal:  Blood       Date:  2018-07-24       Impact factor: 22.113

7.  Long-term type 1 diabetes influences haematopoietic stem cells by reducing vascular repair potential and increasing inflammatory monocyte generation in a murine model.

Authors:  S Hazra; Y P R Jarajapu; V Stepps; S Caballero; J S Thinschmidt; L Sautina; N Bengtsson; S Licalzi; J Dominguez; T S Kern; M S Segal; J D Ash; D R Saban; S H Bartelmez; M B Grant
Journal:  Diabetologia       Date:  2012-11-29       Impact factor: 10.122

8.  Tumor necrosis factor alpha is a potent synergistic factor for the proliferation of primitive human hematopoietic progenitor cells and induces resistance to transforming growth factor beta but not to interferon gamma.

Authors:  H W Snoeck; S Weekx; A Moulijn; F Lardon; M Lenjou; G Nys; P C Van Ranst; D R Van Bockstaele; Z N Berneman
Journal:  J Exp Med       Date:  1996-02-01       Impact factor: 14.307

9.  TNF-α inhibits SCF, ghrelin, and substance P expressions through the NF-κB pathway activation in interstitial cells of Cajal.

Authors:  Keyu Ren; Chunming Yong; Hao Yuan; Bin Cao; Kun Zhao; Jin Wang
Journal:  Braz J Med Biol Res       Date:  2018-04-23       Impact factor: 2.590

Review 10.  Role of TNF-alpha in vascular dysfunction.

Authors:  Hanrui Zhang; Yoonjung Park; Junxi Wu; Xiu ping Chen; Sewon Lee; Jiyeon Yang; Kevin C Dellsperger; Cuihua Zhang
Journal:  Clin Sci (Lond)       Date:  2009-02       Impact factor: 6.124

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.